joint pain glp-1 Stories like this are why so many people are asking about medications. In our latest episode of the Live Yes! With Arthritis Podcast, we explore what these medications are, how they GLP-1 therapy is changing the

Cardiovascular outcome trials (CVOTs) of GLP-1RAs To date, the REWIND study has demonstrated for the first time that primary cardiovascular prevention strategies can significantly reduce cardiovascular adverse events in patients with T2DM, regardless of whether or not these patients are co-diagnosed with CVD [23]

Many patients find electrolyte-containing beverages such as enhanced waters and zero calorie supplements significantly improve feelings of nausea

At 3 months, semaglutide typically produces 6 to 8% weight loss while tirzepatide produces 7 to 10%

Because cardiometabolic regulation reflects signaling across endocrine tissues, liver, adipose tissue, and vascular systems, retatrutide provides a useful probe for studying how coordinated receptor activation shapes systemic biomarker patterns

While weight loss contributes, several direct physiological actions play a major role